flutamide |
13311-84-7 |
Eulexin |
Niftolide |
Niftholide |
2-Methyl-N-4-nitro-3-(trifluoromethyl)phenylpropanamide |
Sch 13521 |
NFBA |
niftolid |
Drogenil |
Flutamin |
Cebatrol, veterinary |
Flutamida |
Flutamidum |
4-Nitro-3-trifluoromethylisobutyranilide |
Sch-13521 |
2-Methyl-N-(4-nitro-3-trifluoromethylphenyl)propanamide |
N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)ISOBUTYRAMIDE |
Propanamide, 2-methyl-N-4-nitro-3-(trifluoromethyl)phenyl- |
SCH13521 |
MFCD00072009 |
NSC 215876 |
Flutamide (Eulexin) |
alpha,alpha,alpha-Trifluoro-2-methyl-4-nitro-m-propionotoluidide |
UNII-76W6J0943E |
CHEMBL806 |
4-Nitro-3-(trifluoromethyl)isobutyranilide |
CHEBI:5132 |
Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)- |
76W6J0943E |
NSC-215876 |
NCGC00015452-09 |
Eulexine |
Chimax |
4-Nitro-3-trifluoromethylisobutyramilide |
CAS-13311-84-7 |
Hams F-12 medium |
Flutamidum INN-Latin |
DSSTox_CID_11121 |
DSSTox_RID_78899 |
DSSTox_GSID_32004 |
Flutamida INN-Spanish |
Flutamide USP25 |
Prostandril |
Odyne |
SMR000058187 |
Eulexin (TN) |
CCRIS 7246 |
m-Propionotoluidide,.alpha.,.alpha.-trifluoro- |
SR-01000075888 |
N-4-Nitro-3-(trifluoromethyl)phenylisobutyramide |
EINECS 236-341-9 |
BRN 2157663 |
.alpha.,.alpha.-Trifluoro-2-methyl-4-nitro-m-propionotoluidide" |
m-Propionotoluidide,.alpha.,.alpha.-trifluoro-2-methyl-4-nitro-" |
4-Nitro-3-(trifluoromethyl)isobutyranilide |
Flutamide USAN:USP:INN:BAN |
Flutamide,(S) |
Prestwick_228 |
NK-601 |
ACMC-20hidt |
Spectrum_001210 |
2-Methyl-N-4-nitro-3-(trifluoromethyl)phenylpropionamide |
CPD000058187 |
Prestwick0_000180 |
Prestwick1_000180 |
Prestwick2_000180 |
Prestwick3_000180 |
Spectrum2_001201 |
Spectrum3_001421 |
Spectrum4_000829 |
Spectrum5_001450 |
Lopac-F-9397 |
F0663 |
Flutamide (pubertal study) |
F 9397 |
SCHEMBL3934 |
Lopac0_000557 |
BSPBio_000079 |
BSPBio_003122 |
KBioGR_001377 |
KBioSS_001690 |
MLS000069634 |
MLS001065596 |
MLS002548892 |
DivK1c_000459 |
SPECTRUM1500995 |
SPBio_000982 |
SPBio_002000 |
Flutamide (JP17/USP/INN) |
BPBio1_000087 |
GTPL6943 |
DTXSID7032004 |
SCHEMBL12932289 |
HMS501G21 |
KBio1_000459 |
KBio2_001690 |
KBio2_004258 |
KBio2_006826 |
KBio3_002342 |
NINDS_000459 |
HMS1568D21 |
HMS1921O16 |
HMS2090I18 |
HMS2092O14 |
HMS2095D21 |
HMS2230P19 |
HMS3259I03 |
HMS3261P15 |
HMS3373C12 |
HMS3655G22 |
HMS3712D21 |
Pharmakon1600-01500995 |
AMY32524 |
BCP23006 |
HY-B0022 |
ZINC3812944 |
Tox21_110154 |
Tox21_202169 |
Tox21_300536 |
Tox21_500557 |
BDBM50131270 |
CCG-39105 |
m-Propionotoluidide, 2-methyl-4-nitro-alpha,alpha,alpha-triflouro- |
NSC147834 |
NSC215876 |
NSC757817 |
s1908 |
SBB006930 |
AKOS001025465 |
AKOS025243203 |
m-Propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4-nitro- |
Tox21_110154_1 |
AB02835 |
DB00499 |
KS-5091 |
LP00557 |
MCULE-7498839065 |
NC00451 |
NSC-147834 |
NSC-757817 |
SDCCGSBI-0050540.P004 |
IDI1_000459 |
NCGC00015452-01 |
NCGC00015452-02 |
NCGC00015452-03 |
NCGC00015452-04 |
NCGC00015452-05 |
NCGC00015452-06 |
NCGC00015452-07 |
NCGC00015452-08 |
NCGC00015452-10 |
NCGC00015452-11 |
NCGC00015452-12 |
NCGC00015452-13 |
NCGC00015452-14 |
NCGC00015452-15 |
NCGC00015452-16 |
NCGC00015452-19 |
NCGC00015452-20 |
NCGC00015452-32 |
NCGC00091460-01 |
NCGC00091460-02 |
NCGC00091460-03 |
NCGC00091460-04 |
NCGC00091460-05 |
NCGC00091460-06 |
NCGC00091460-07 |
NCGC00091460-08 |
NCGC00091460-09 |
NCGC00254495-01 |
NCGC00259718-01 |
NCGC00261242-01 |
AC-24192 |
BF166239 |
ST058409 |
SY036411 |
SBI-0050540.P003 |
AB0005010 |
DB-042163 |
3-Trifluoromethyl-4-Nitro-Isobutyranilide |
AB00052188 |
EU-0100557 |
FT-0626493 |
FT-0668764 |
SW196536-4 |
4-nitro-3-trifluoromethylisobutyranilide |
C07653 |
D00586 |
J10037 |
AB00052188-09 |
AB00052188_10 |
AB00052188_11 |
311F847 |
A806562 |
Q418669 |
Q-201131 |
SR-01000075888-1 |
SR-01000075888-6 |
SR-01000075888-7 |
SR-01000075888-9 |
BRD-K28307902-001-05-0 |
Flutamide, certified reference material, TraceCERT(R) |
Z56755651 |
a,a,a-Trifluoro-2-methyl-4-nitro- m-propionotoluidide |
Flutamide, European Pharmacopoeia (EP) Reference Standard |
2-Methyl-N-4-nitro-3-(trifluoromethyl)phenylpropanamide # |
Flutamide, United States Pharmacopeia (USP) Reference Standard |
2-methyl-N-4-nitro-3-(trifluoromethyl)phenylpropanamide;Flutamide |
alpha,alpha,alpha-trifluoro-2-methyl-4-nitro-m-propionotoluidide" |
.alpha.,.alpha.,.alpha.-Trifluoro-2-methyl-4-nitro-m-propionotoluidide" |
m-Propionotoluidide, 2-methyl-4-nitro-.alpha.,.alpha.,.alpha.-trifluoro-" |
m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4-nitro- (8CI) |
Flutamide for system suitability, European Pharmacopoeia (EP) Reference Standard |
37209-54-4 |
|